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1, INTRODUCTION 
Protein kinasc(s) C constitutes a family of Ca2”, 
phospholipid-dependent serine/thrconine specific 
kinases which regulate multiple cellular processes and 
are activated by diacylglycerol, acting as a ‘second 
messenger’ for cell surface interactive stimuli [I]. Re- 
cent studies have shown that insulin stimulates PKC 
translocation from the cytosol to the particulate frac- 
tion in adipocytes [2,3], suggesting that PKC is involved 
in mediating insulin action. Several approaches have 
been used to investigate the role of PKC in insulin- 
stimulated signal transduction, including prolonged in- 
cubation with phorbol esters to ‘down-regulate’ PKC 
[4], as well as the use of biochemical and biological in- 
hibitors of the regulatory and catalytic domains of PKC 
[5,6]. Each of these experimental designs, while useful, 
is somewhat limited, It is now becoming increasingly 
recognized that chronic incubation with biologically ac- 
tive phorbof esters may lead only to selective isozyme 
down-regulation, and that even partial retention of 
PKC may be sufficient o fully evoke the agonist effect 
in some cell types [7]. Furthermore, the use of inhibitors 
of PKC may be difficult to interpret due to possible 
non-specific inhibition of other cellular kinases. 
Kemp and House [8] have reported that cytosolic 
PKC activity is autoregulated (inhibited) by an 18 
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amino acid sequence (PKC( 19-36)), found in the highly 
conserved amino-terminus, which functions as a 
pseudosubstrate for the carboxy-terminus catalytic site, 
Since it has been shown that this pseudosubstrate motif, 
as well as a 13 amino acid subset (PKC(19-3E)), is a 
highly specific competitive inhibitor of PKC [g), this 
suggested that the pseudosubstrate could be used to in- 
vestigate ttie role of PKC in insulin or other hormone 
action, in this study, WC have studied the effects of 
PKC( 19-3 1) on insulin-stimulated lipogenesis and 
glucose uptake in intact and electroporated rat 
adipocytcs. 
2. MATERIALS AND METHODS 
[‘HIS-DOG (30 Ci/mmol) was purchased from New England 
Nuclear (Boston, MA) and [6-‘HID-glucose (38 Ci/mmol) and Cyto- 
Stint scintillation cocktail were from ICN Biomedicals (Costa Mesa, 
CA), Insulin was purchased from ELANCO (Indianapolis, IN) and 
PMA was from Sigma. Collagenase was from Worthington 
(Freehold, NJ). PKC(l9-36) was purchased from Bachem (Torrance, 
CA). Synthetic pcptide amides, corresponding to the PKC sequence 
19-31 as well as an unrelated 15 amino acid sequence 
(ALDTNYSFSSTEKNC) corresponding to the N-terminal 15 amino 
acids of transforming growth factor-p, were synthesized using t-Boc 
chemistry and PAM resins by established methods [9,10] employin 
an automated peptide synthesizer (model 430A; Applied Biosystems 
Inc., Foster City, CA), At the end of the synthesis the peptides were 
cleaved from the resin by anhydrous liquid hydrogen fiuoride and 
desalted by gel filtration. 
2.2. Methods 
Isolated rat adipocytes were prepared from nonfasted male 
Holtzman rats (1 SO-200 g body weight) by collagenase treatment [ 111. 
Cells (6% srtapeasian in KRP + 1% BSA) were pre-equilibrated at 
37°C to restore adenosine levels, treated in the presence or absence of 
the peptide sequences for 30 min and then in the presence or absence 
of 3 nM insulin or 500 nM PMA for an additional 30 min. One min 
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1t1c lipid rrncrion afthe utllpocytm. D&fly, 0.5 nil or a 6% tidipaeyre 
nuspmxionn Were inuubntcd in the presence or abxcncc ur PKC(I9-31) 
for 30 min nllrr which 3 nM IN% wtlbi added IO selsc~~l actmplcs fur 
IO m/n, nntl rhcn I peiaT(B.LCt)U~UI~iedri: (0. I mhf gluroxrc, finfll con- 
centration) was added to all ramplea which wcrr Incub~rcd rar mi nd. 
ditionul 30 min. The reaction WQS tcrminatcd by the addition of 2 ml 
cold mc~henol, and lipidr were cxrr~cted with 4 ml chlaroferm. The 
chloroform/nrcrhnnol (2:l) nrlxrurc wns washed 3 1imc4 with 2 ml 
water rnd JO0 pl rliquota of the chloroform cxtracls were dried and 
the lipid-incorporated radiouctivily determined. 
3. RESULTS 
3.1, Efjecrs of PKC (19-31) pseudosubsrrate on insulin 
and PMA sritmlared 2-DOG uprake in intact 
adipocytes 
As shown in Fig. 1 (left panel), PKC(19-31) 
pseudosubstrate caused a dose-dependlcnt i hibition of 
both insulin- and PMA-stimulated hexosc uptake in 
isolated intact adipocytcs. In this experiment, insulin 
As further shown in Fig 1 (right panel), 5 nM insulin 
provoked a 4.fold increase in the incorporation of 
(6.‘W]B-&~cose ints the lipid fraction of ixotated 
adipocyres. PKC( 19-3 1) inhibited in~ulin~stirnulatctl 
lipogenesis in a pattern analogous to insulin~stimulatcd 
hexoec transport. PKC( 19-31) had little effect on basal 
levels of lipsgenesis, had little effect on insulin action at 
80 p!vI PKC(19-311, but was fully effective in blocking 
insulin-stimulated lipogenesis at 800 PM pseudo- 
substrate. 
3.3. EffiWs of vurious peplides on insrrlin-sfittlrrla~~d 
ltexose uptake itI inracl adipoeyres 
As shown in Fig. 2, in studies utilizing intact 
adipocytes, PMA-stimulated hcxose uptake was more 
sensitive to PKC(19-31) inhibition than was insulin- 
stimulated hexosc uptake: respective K&s for PMA 
and insulin were 300 PM and 600 $vl PKC( 19-3 l), The 
entire pseudosubstrate amino acid sequence described 
yM PKC (19-31) /rtvl PKC (IF)-31) 
Fig. 1, Dose-dependent effects of PKC(lY-3 1) on insulin- and PMA-stimulated 2-DOG uptake (left panel). Dose-dependent effects of PKC(lP-31) 
on insulin-stimulated lipogenesisin intact adipocytes (right panel). Values are the mean 5~ SE of triplicate determinations from representative ex- 
periments, 
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by House and Kemp, PKC(l9-36), also blocked insulin- 
stimulated 2.DOG uptake to approximately the same 
extent as PKC(l9-31). Each largely blocked the insulin 
cffecc at 600-800 @I concentrations. Incubation with 
an unrelated amino acid sequence corresponding to the 
N-terminal 15 amino acids of transforming growth 
factor-p had no effect on insulin-stimulated hexose up- 
take. 
3.4. Effect of PKC(lP-31) or1 itrsulin-stimltlated 
hexose transport in electroporuted rat adipocytes 
When adipocytes were electroporated in the presence 
of PKC(l9-31), insulin-stimulated hcxose transport 
was markedly more sensitive to PKC(l9-31), with an 
ICSO of 30 PM PKC(l9-31) compared to 600 FM in in- 
tact adipocytes (Fig. 2). 
4. DISCUSSION 
Several studies have now suggested a role for PKC in 
insulin-stimulated hexose transport in isolated rat 
adipocytes. Insulin-stimulates PKC activity [13,14] and 
translocation [2,3] in these cells. Furthermore, treat- 
ment with activators of PKC including exogenous 
diacylglycerols [15,161, phospholipase 6, which in- 
creases endogenous diacylglycerol 1163, and biologically 
active phorbol ester diacylglycerol anatogues 1171 each 
stimulate hexose transport in the adipocyte in an 
insulin-like manner. Recently, Haring and colleagues 
[ 181 have proposed a two-step model for insulin-action 
in adipocytes in which PKC is involved in insulin- 
stimulated recruitment of glncase transpurters from the 
microsomal fraction to the plasma membrane. 
In this investigation, we have studied the effect of a 
specific PKC inhibitor on insulin-stimulated hexose 
transport. House and Kemp [8] have reported that a 
specific, arginine-rich sequence, PKC( 19-36), within 
the highly conserved Cl region of PKC, inhibits the 
scrine/threonine kinase activity of the catalytic domain. 
In our study, we have shown the incubation of either in- 
tact or electroporated adipocytcs with PKC( 19-3 1), 
also an effective pseudosubstrate s quence [fl], blocked 
insulin- and PMA-stimulated hcxose transport aPMA- 
stimulated hcxose uptake was somewhat more sensitive 
to PKC(l9-31) than was the insulin effect on hexose up- 
take, wit,h respective 16~0s of 300 FM and 600 ,uM. This 
difference in insulin and PMA sensitivity is consistent 
with that previously observed for other PKC inhibitors, 
viz. H-7, sangivamycin, and staurosporine in 
adipocytes, and is consistent with a two-step model in 
which insulin activation of PKC may be involved 
primarily in mediating insulin-stimulated glucose 
transporter translocation with insulin further activating 
glucose transporters by a PKC-independent mechan- 
ism. Alternatively, the differential sensitivities to in- 
hibitors may reflect agonist specific, i.e. PMA vs 
diacylglycerol (insulin), effects on specific PKC 
isozyme activation. Along the latter lines, PKC in- 
hibitors are equally effective when insulin concentra- 
tions are used which evoke glucose transport responses 
comparable to that of PMA [6]. Additionally, as noted 
with other PKC inhibitors [6], the inhibitory effect of 
PKC(19-31) was quite sharp with the full effect of the 
inhibitor evidenced over a single order of magnitude. 
Relatively high molecular concentrations of 
pseudosubstrate were required to inhibit PMA or in- 
sulin action in intact adipocytes. However, when elec- 
troporated adipocytes were treated with PKC(19-31) 
the effective concentration required to inhibit insulin- 
stimulated hexose uptake was reduced lo-20.fold, from 
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an ICp3 of 600 pM in intact adipoeytes to an CCfg Of 26) 
j4M. in elcclreparrtccl adipacytrk The httcr value is En 
reasonable agreement with rcsultr athers have abservcd 
in cell4hc systemx. Far example, fl cancencration sf 3 
mN PKC(19-31) delivered by m.icmelcctrodc impale- 
ment with n 30.min diffusion rime was required to con- 
sistently inhibit long-term porentiation of synaptic 
transmirsion [I’ll, white 20 min treatment with 100 j&l 
$KC(19-3 I) failed to block h-q-term petentintion 
following tctanic trimulatian. Additionally, the EC& 
for PKC( 19-3 1)inhibirian of ychain phoaphorylation 
in streptolysin-O-permleabilixecl T=lymphocyres is 7-20 
PM [20], and rcrroinverso PKC(l9-31) inhibired 
purified brain PKC pheophorylation of glycogen syn- 
thasc I-12 at an IC~O al 31 PM [al]. These differences 
in observed ICsas most probably reflect the variable af- 
finity of PKC isoaymca for the phosphory!ation of 
specific substrates. Whcrcas the I&I for PKC(19-31) 
using a synthetic sequence of glycagen synthase and 
purified rat brain PKC is 90 nM PKC pseudosubstrate 
[8), the ICJO for inhibition by PKC( 19-3 I) is 1 PM using 
purified PKC from EL4 thymoma cells and histone 111s 
substrate (221. Additionally, as evidenced by the in- 
creased efficacy of PKC( 19-3 1) in electroporated cells, 
the higher pseudosubstrate concentrations required for 
inhibition of insulin action in intact adipocytes may 
reflect permeability factors, as well as the presence of 
multiple PKC cellular substrates, with varying affinities 
for PKCmcdiated phosphorylation. Indeed, uptake of 
radiolabeled inositol was increased from 0.2% of the 
applied radioactivity in intact cells to 2,5% in clec- 
troporated cells [23). This indicates that clectroporation 
increases cellular uptake of the applied pscudosub- 
strate; however, intracellular concentrations of 
PKC(19-31), while increased, may not attain extra- 
cellular levels due to the transient nature of membrane 
pore formation. In our study, the cytochalasin B values 
for 2-DOG uptake in intact and electroporated adipo- 
cyte were almost identical indicating rapid resealing of 
the electroporated-induced membrane pores (143 f 11 
cpm per assay in intact adipocytes and 169 f 5 cpm per 
assay in electroporated adipocytes). 
As recently demonstrated by Krebs and colleagues 
PKC(19-31) is a more selective inhibitor of PKC than 
the more widely used inhibitors staurosporine and H-7 
and has no effect in vitro on either ribosomai S6 kinase 
or myelin basic protein kinase at concentrations below 
1 mM [22]. In conclusion, our findings indicate that 
BKC(l4-3 I) uan rf’k~tiuely be teed to xtudy the role af 
PKC in harmonc action In intact and electraporntcct rnt 
tldiptxyta and provide ndditianni evidetva indknrin~ 
that PKC may be invalvcd in inxulin~xtimulnted hcxexe 
trwn%port and lipagav?nis in iscllatcd rat adipeeytea. 
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